HK1149956A1 - Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex - Google Patents

Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex

Info

Publication number
HK1149956A1
HK1149956A1 HK11103810A HK11103810A HK1149956A1 HK 1149956 A1 HK1149956 A1 HK 1149956A1 HK 11103810 A HK11103810 A HK 11103810A HK 11103810 A HK11103810 A HK 11103810A HK 1149956 A1 HK1149956 A1 HK 1149956A1
Authority
HK
Hong Kong
Prior art keywords
colorectal cancer
calprotectin
hemoglobin
stool sample
haptoglobin complex
Prior art date
Application number
HK11103810A
Other languages
English (en)
Inventor
Johann Karl
Ursula Garczarek
Norbert Wild
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1149956A1 publication Critical patent/HK1149956A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
HK11103810A 2007-11-20 2011-04-15 Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex HK1149956A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07022448 2007-11-20
PCT/EP2008/009733 WO2009065551A1 (en) 2007-11-20 2008-11-18 Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex

Publications (1)

Publication Number Publication Date
HK1149956A1 true HK1149956A1 (en) 2011-10-21

Family

ID=40134824

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103810A HK1149956A1 (en) 2007-11-20 2011-04-15 Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex

Country Status (8)

Country Link
US (2) US20110129860A1 (xx)
EP (1) EP2212700B8 (xx)
JP (1) JP5227418B2 (xx)
CN (1) CN101868729B (xx)
AT (1) ATE521894T1 (xx)
CA (1) CA2701341C (xx)
HK (1) HK1149956A1 (xx)
WO (1) WO2009065551A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5700392B2 (ja) * 2010-03-29 2015-04-15 独立行政法人国立高等専門学校機構 生体試料の調製法
ES2380664B2 (es) 2010-10-19 2012-09-13 Certest Biotec, S.L. Método y dispositivo para el diagnóstico rápido de enfermedades en muestras fecales.
GB201021509D0 (en) * 2010-12-20 2011-02-02 Reactivlab Ltd Assay method
US10072300B2 (en) 2013-05-21 2018-09-11 Biomerieux Kit for the prognosis of colorectal cancer
EP2947459B1 (en) * 2014-05-21 2017-07-12 Bühlmann Laboratories AG Method for determination of a protein
EP3250710B1 (en) 2015-01-30 2018-08-22 Enterome Host dna as a biomarker of crohn's disease
CN104614371A (zh) * 2015-02-15 2015-05-13 史春龙 一种在便器中检测排泄物生化指标的方法及使用该方法的检测设备
JP2018517892A (ja) 2015-04-10 2018-07-05 アプライド プロテオミクス，インク． 結腸直腸癌と進行腺腫を検知するためのタンパク質バイオマーカーパネル
WO2017146647A1 (en) * 2016-02-22 2017-08-31 Agency For Science, Technology And Research Method for detecting an analyte using surface enhanced raman spectroscopy
CN110383067B (zh) * 2016-05-30 2023-07-21 荣研化学株式会社 抗人血红蛋白单克隆抗体或抗体试剂盒、抗体固定化不溶性载体粒子和它们的应用
CN106814189B (zh) * 2016-12-20 2018-10-26 成都金思唯生物技术有限公司 一种检测艰难梭菌的试剂盒及其用途
CN108333368A (zh) * 2018-02-07 2018-07-27 深圳市伯劳特生物制品有限公司 一种检测人粪便中钙卫蛋白的试剂盒及制备方法
CN112578123B (zh) * 2019-09-27 2022-10-25 成都中医药大学 检测粪钙卫蛋白含量的试剂在制备子宫病变筛查试剂盒中的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198365A (en) * 1987-02-04 1993-03-30 International Immunoassay Laboratories, Inc. Fecal sample immunoassay method testing for hemoglobin
US5455160A (en) * 1993-05-27 1995-10-03 Fagerhol; Magne K. Diagnostic test and kit for disease or disorders in the digestive system
ATE278964T1 (de) * 1996-11-01 2004-10-15 Magne K Fagerhol Verfahren zur proteinextraktion
AUPP713498A0 (en) * 1998-11-17 1998-12-10 Chandler, Howard Milne A method of detecting blood
WO2002080775A1 (en) * 2001-04-04 2002-10-17 Enterix Inc. Method of collecting a gastrointestinal tract sample
JP2004251851A (ja) * 2003-02-21 2004-09-09 Japan Clinical Laboratories Inc 糞便成分の検査方法
EP1724585A1 (en) * 2005-05-21 2006-11-22 ProteoSys AG Annexin for cancer risk assessment
CN101341410A (zh) * 2005-12-21 2009-01-07 霍夫曼—拉罗奇有限公司 通过测量粪便样品中血红蛋白和m2-pk的评定结肠直肠癌的方法
KR101147586B1 (ko) * 2006-05-19 2012-08-23 에프. 호프만-라 로슈 아게 결장직장암에 대한 마커로서 단백질 ｓ100ａ12 의 용도
CN101680898A (zh) * 2007-05-10 2010-03-24 霍夫曼-拉罗奇有限公司 Timp-1作为结肠直肠癌标志的用途

Also Published As

Publication number Publication date
JP5227418B2 (ja) 2013-07-03
US20110129860A1 (en) 2011-06-02
CN101868729A (zh) 2010-10-20
ATE521894T1 (de) 2011-09-15
EP2212700B1 (en) 2011-08-24
CN101868729B (zh) 2013-07-17
CA2701341A1 (en) 2009-05-28
EP2212700B8 (en) 2011-10-12
EP2212700A1 (en) 2010-08-04
US20150126401A1 (en) 2015-05-07
CA2701341C (en) 2012-03-20
JP2011503593A (ja) 2011-01-27
WO2009065551A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
HK1149956A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
IN2013CN01129A (xx)
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
PL1721162T3 (pl) Sposób oceny reumatoidalnego zapalenia stawów przez pomiar anty-CCP oraz amyloidu A w surowicy
WO2010096154A3 (en) Compositions and methods for diagnosis and prognosis of colorectal cancer
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
EP1996718A4 (en) TOXICITY SCREENING PROCESS
CY1111229T1 (el) Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6
WO2011021041A3 (en) Survival prognostic assay
DK2185939T3 (da) Engangsanalyseudstyr med mikroprocessor
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
WO2010000467A8 (en) Asc as a marker for lung cancer
NZ601643A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
GB2456690A (en) A method for quantitative detection of diabetes related immunological markers

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171118